Halozyme Therapeutics, Inc. · NASDAQ:HALO
Duncan Barbara Gayle received 3,796 Halozyme Therapeutics, Inc. shares as an award (Form 4)
Traded May 5, 2026 · Filed May 7, 2026
On May 5, 2026, Duncan Barbara Gayle (Director) received 3,796 Halozyme Therapeutics, Inc. shares as an award, leaving 23,715 shares. Filed May 7, 2026 (Form 4).
- Awarded
- 3,796 shares
- Holding after
- 23,715 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 5, 2026 | Common Stock | Award | 3,796 | 23,715 | Direct |